Preparation method and application of electrochemical luminescence immunosensor based on AIECL
By designing a new A-π-D-π-A molecule BDPPA with highly distorted molecular conformation and efficient intramolecular charge transfer, and preparing BDPPANPs, an efficient electrochemiluminescence immunosensor was constructed, which solved the high cost of materials in the inorganic AIECL system and The problem of low ECL efficiency of organic AIECL luminescents has achieved high sensitivity SARS-CoV-2N protein detection and biosensing applications.
Patent Information
- Application Number
- CN202411005515.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing inorganic AIECL system has high material costs and complex synthesis conditions. The ECL response of the organic AIECL luminescent in aqueous media is limited by the internal filtering effect and self-quenching effect, resulting in low ECL efficiency.
A new A-π-D-π-A molecular BDPPA with highly distorted molecular conformation and efficient intramolecular charge transfer was designed. BDPPANPs were prepared by nanoprecipitation method, and an electrochemiluminescent immunosensor based on BDPPANPs was constructed, which was used to utilize its excellent performance. The co-reacting dosage form ECL behavior and ICT effect improve ECL luminescence efficiency.
Significantly improve the ECL luminescence efficiency, realize high-sensitivity SARS-CoV-2N protein detection, and provide an efficient label-free immune sensor with excellent specificity, sensitivity and reliability. The ECL luminescence efficiency can reach 54%, which is suitable for biosensing applications.
Smart Images

Figure CN118962128A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biological detection technology, and specifically to a preparation method and application of an electrochemiluminescence immunosensor based on aggregation-induced electrochemiluminescence (AIECL), and more specifically to a novel AIECL luminophore (BDPPANPs) with efficient intramolecular charge transfer (ICT) effect and highly distorted molecular conformation. Due to the efficient intramolecular charge transfer and highly distorted conformation leading to enhanced luminescence efficiency of the aggregated state, a label-free ECL immunosensor is constructed for high-sensitivity detection of SARS-CoV-2N protein. Background Art
[0002] Electrochemiluminescence (ECL) is a phenomenon in which an electrode produces high-energy substances through a series of redox reactions. Due to its unique advantages such as no need for additional light sources, low background, strong controllability and high sensitivity, ECL has become an important means of sensitive analytical technology in the fields of ECL devices, bioanalysis and bioimaging. Recently, aggregation-induced electrochemiluminescence (AIECL) has attracted widespread interest because it combines the advantages of aggregation-induced emission (AIE) and ECL. By restricting the free rotation and twisting of molecules, the ECL response of the aggregated state is significantly increased. Various organic and inorganic AIECL systems have been developed: organic systems include point aggregates and nanocrystals formed by organic small molecules; inorganic systems include metal complexes and metal nanoclusters. However, the AIECL systems developed in inorganic systems are mainly composed of precious metals (such as Au, Pt, Ru, etc.) and rare metals (such as Zr, etc.), which have problems such as high cost, harsh synthesis conditions and complex reaction steps. In contrast, organic systems are considered to be one of the excellent candidates in the field of AIECL due to their advantages such as structural diversity, low cost and adjustable photophysical properties. Undoubtedly, the ECL response of current organic AIECL luminophores in aqueous media exceeds that of dispersed molecular states in organic systems. However, the densely packed molecules within the aggregates lead to significant internal filtering and self-quenching effects, limiting the ECL efficiency. Therefore, exploring new AIECL organic luminophores with high ECL efficiency, affordability, and low biotoxicity is a worthy research topic. Therefore, designing organic molecules with twisted structures is a promising approach to develop new luminophores with aggregation-induced emission (AIE) and AIECL properties. In addition, effective regulation of intramolecular charge transfer within donor-acceptor (DA) groups in conjugated polymers has been shown to improve AIECL performance. Therefore, incorporating twisted molecular structures and intramolecular charge transfer within donor-acceptor (DA) groups into the molecular structure is a promising strategy to develop new AIECL luminophores.
[0003] On this basis, a new A-π-D-π-A molecule (BDPPA) with highly twisted molecular conformation and efficient intramolecular charge transfer transition was developed for AIECL for the first time. BDPPANPs exhibited strong ECL at the anode and cathode. This will open up a way to find efficient AIECL luminophores and provide a reference for the development of efficient platforms for biosensing, luminescent devices and ECL imaging. There is no literature on the relevant content. Summary of the invention
[0004] In view of this, the purpose of the present invention is to develop a new type of AIECL emitter (BDPPANPs) in which the efficient intramolecular charge transfer effect and highly twisted conformation contribute to significantly enhanced ECL. The ICT effect reduces the electron transfer pathway, while the twisted conformation effectively restricts π-π stacking and intramolecular motion. 2+ ] / TPrA's standard ECL system, its ECL luminescence efficiency (Φ ECL ) can be as high as 54%, and ECL can be directly observed through the co-reactant route. In addition, a highly sensitive SARS-CoV-2N protein biosensor platform was constructed.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides a method for preparing a highly efficient aggregation-induced electrochemiluminescence immunosensor based on intramolecular charge transfer and distorted molecular conformation, comprising the following steps:
[0006] Step 1, preparing BDPPA small molecule;
[0007] Step 2: synthesize BDPPANPs by nanoprecipitation method; the obtained product is spherical and has good dispersibility; BDPPANPs has the structure of acceptor-conjugated bridge-donor-conjugated bridge-acceptor (A-π-D-π-A), and has excellent co-reactant ECL.
[0008] Step 3: Construction of electrochemiluminescent immunosensor:
[0009] S1. GCE was polished with 1.0, 0.3, and 0.05 μm alumina powder, respectively, and then cleaned alternately in ethanol and ultrapure water using ultrasonic waves.
[0010] S2. Add 6 μL of prepared BDPPANPs (160 μg mL -1 ) dispersion was poured onto the GCE surface and dried at 25 °C to prepare BDPPANPs / GCE.
[0011] S3. The above NPs-modified GCE was immersed in a cross-linking agent (20 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)) and 10 mM N-hydroxysuccinimide (NHS) and incubated at room temperature for 30 min.
[0012] S4. Incubate 4 μL Ab (10 μg / mL) with the modified electrode at 4 °C for 12 h (Ab / BDPPA NPs / GCE), and then incubate with 4 μL BSA (1%) (BSA / Ab1 / BDPPANPs / GCE) at 25 °C for 30 min to prevent nonspecific adsorption.
[0013] S5. 10 μL of SARS-CoV-2N protein with different concentrations was incubated with the modified electrode BSA / Ab1 / BDPPA NPs / GCE at 37 °C for 60 min to prepare a label-free immunosensor for antigen-antibody specific recognition. After each modification step, PBS (0.01 M, pH 7.4) was used to remove weak binding components.
[0014] The above-mentioned efficient aggregation-induced electrochemiluminescence immunosensor based on intramolecular charge transfer and distorted molecular conformation was used for quantitative analysis of SARS-CoV-2 N protein. Based on the excellent anodic ECL performance of the BDPPANPs / TPrA system, a typical label-free immunosensor was established using BDPPANPs as a probe. Suitable detection conditions were obtained by optimizing the pH value and incubation time. Under the optimal conditions, the ECL intensity gradually decreased with the increase of N protein concentration, providing an indicator for the detection of SARS-CoV-2 N protein.
[0015] Compared with the prior art, the present invention has the following beneficial effects:
[0016] (1) First, the BDPPA small molecule was synthesized, and then BDPPANPs were prepared by the nanocoprecipitation method. The resulting product was spherical and had good dispersibility. BDPPANPs has the structure of acceptor-conjugated bridge-donor-conjugated bridge-acceptor (A-π-D-π-A) and has excellent co-reactant ECL behavior.
[0017] (2) A typical label-free immunosensor was established using BDPPANPs as probes. The prepared BDPPANPs provided a strong anodic ECL signal due to the enhanced ECL emission under the highly twisted conformation induced by aggregation. At the same time, the DA group was introduced into the molecular structure to achieve an efficient ICT effect, thereby improving the ECL performance of AIECL. It is helpful for the sensitive detection of SARS-CoV-2N protein. In addition, the proposed strategy showed excellent specificity, sensitivity, and reliability in detecting SARS-CoV-2N protein in aqueous solution and human serum.
[0018] (3) with [Ru(bpy)3 2+ ] / TPrA standard system, its ECL luminous efficiency (Φ ECL ) can be as high as 54%. The effective intramolecular charge transfer (ICT) effect and highly twisted conformation significantly improve its ECL luminescence efficiency. The improvement of ECL efficiency indicates that AIECL has important application value in improving ECL efficiency and promoting biosensing applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 .BDPPA molecular synthesis pathway diagram in the present invention.
[0020] Figure 2 .(A) is the fluorescence spectrum of BDPPA molecules in THF / water mixed solution with different water volume fractions (f w ) changes from 0% to 90% (the inset shows the corresponding luminescence photograph under 365nm UV light). (B) is the calculated spatial distribution of HOMO and LUMO electron density. (C) is the dihedral angle between the central benzene ring and the phenyl group with a substituted group, and (D) is the molecular stacking structure of BDPPA in the crystal structure. For clarity, the relevant hydrogen atoms have been omitted.
[0021] Figure 3 .Characterization diagrams of BDPPANPs in the present invention: (A) is a TEM image of BDPPANPs (the inset is the size distribution of BDPPANPs measured by DLS). (B) is the UV-visible absorption and fluorescence spectra of BDPPANPs (the inset is a photograph of BDPPANPs aqueous solution under 365nm UV irradiation and without irradiation). (C) is a single particle fluorescence image of BDPPANPs. (D) is a three-dimensional surface image of the fluorescence image.
[0022] Figure 4 .(A) Schematic diagram of the ECL mechanism of BDPPANPs; (B) The construction process of the label-free immunosensor.
[0023] Figure 5.(A) ECL-time curves of bare GCE in TBAPF6 THF solution (0.10 M) containing 25 mM TPrA and BDPPA monomers (black line) and ECL-time curves of GCE-modified BDPPANPs in PBS (0.10 M) containing 25 mM TPrA (red line) (Figure: Comparison of ECL intensity between BDPPA monomer and aggregate; magnification factor set to 100, PMT adjusted to 1080 V). (B) Cyclic voltammogram; (C) Corresponding ECL-potential curves: in 0.1 M KNO3 PBS (0.1 M, pH 7.4), at 100 mV s -1 ECL-potential curves of bare GCE in the presence of 25mM TPrA (curve a), BDPPANPs (curve b) and 25mMTPrA (curve c) at a scan rate of . The inset of Figure C is the enlarged curves a and b. (D) is the normalized fluorescence and ECL spectra of the BDPPANPs film obtained by applying a constant potential of +1.60V for 20s in 0.1M PBS containing 0.1M KNO3 and 25mM TPrA (the inset is the ECL image). (E) is the CIE color map of the ECL and PL emission of BDPPANPs.
[0024] Figure 6 (A) ECL responses of the immunosensor to different concentrations of N protein [(aj): 0.001, 0.003, 0.01, 0.05, 0.2, 0.5, 2, 10, 50, 100 and 500 ng mL -1 ]. (B) is the calibration curve of N protein detection. (C) is the potential interference: IL-6 (10ng mL -1 )、CEA(10ng mL -1 )、CRP(10ng mL -1 ), IL-8 (10 ng mL -1 ), N protein (1ng mL -1 ) and the mixture of N protein and the above proteins, the selectivity of the immunosensor in detecting N protein. (D) -1 The long-term storage stability of the proposed immunosensor was evaluated by incubation with 2 ng mL N protein. (E) In PBS (pH 7.4) containing 25 mM TPrA, 2 ng mL -1 N protein was incubated with GCE / BDPPANPs / Ab / BSA, and intra-group (a) and inter-group (b) studies were performed (error bars = SD, n = 3). DETAILED DESCRIPTION
[0025] Reagents and instruments used in the following examples are: All chemicals and solvents were purchased from commercial sources without further purification. Styrene-comaleic anhydride (Poly), isopropylamine (PSMA), (average Mn: 1900), tetrabutylammonium perchlorate (Bu4NClO4), ferrocene carboxylic acid and potassium persulfate (K2S2O8) were obtained from Macklin, Shanghai, China. Bis(dibenzylacetone)palladium(0) [Pd2(dba)3], 2-dicyclohexylphospho-2′,6′-diisopropoxybiphenyl (Ruphos), triethylamine (TEA), tri-n-propylamine (TPrA), 2-dibutylamineethanol (DBAE) were purchased from Aladdin Biochemical Technology Co., Ltd., Shanghai, China. 4-Fluorobenzeneacetonitrile was purchased from heown. Phosphate buffered saline (PBS, 0.1 M) was prepared by mixing NaH2PO4, Na2HPO4 and KNO3 stock solutions. Bovine serum albumin (BSA) was purchased from Sigma-Aldrich. SARS-CoV-2 N protein, N protein capture antibody (Ab), interleukin-6 (IL-6), carcinoembryonic antigen (CEA), C-reactive protein (CRP), and interleukin-6 (IL-8) were purchased from Lingchao Biotechnology Co., Ltd. (Shanghai, China). Human plasma was provided by the Affiliated Hospital of Nantong University (Nantong, China). All aqueous solutions used ultrapure water (18.2 MΩ cm) from the Millipore system.
[0026] Transmission electron microscopy (TEM) images were obtained using a FEI Talos F200X TEM (Thermo Scientific, USA). Fluorescence measurements were performed using a FS5 fluorescence spectrophotometer (Edinburgh Instruments Ltd., UK). UV-visible absorption spectra were performed using a UV-1900 spectrophotometer (Shimadzu, Japan). DLS measurements were obtained using a Zetasizer Nano ZS90 laser diffraction particle size analyzer (Marlvern, UK). 1H NMR spectra were recorded using a Bruker Ultra ShieldPlus (400MHz) spectrometer with tetramethylsilane (TMS, δ=0ppm) as the internal standard. 13C nuclear magnetic resonance spectra were measured on a Bruker Ultra ShieldPlus (400MHz) spectrometer. Single particle fluorescence images were taken on a Nikon-ti2 microscope with a 60× immersion objective.
[0027] All electrochemiluminescence (ECL) times and ECL potential curves were recorded by a BPCL-GP21Q ultra-weak luminescence analyzer (Guangzhou Weiguang Technology Co., Ltd., China) equipped with a CHI 660E electrochemical workstation (CH Instrument Co., Ltd., USA). The photomultiplier tube (PMT) used for ECL measurement was biased at 1080 V (different PMT values are indicated in the text). Electrochemical impedance spectroscopy (EIS) was performed by an Autolab PGSTAT 302N electrochemical station (Metrohm Technology Co., Ltd., Switzerland). The above measurements all used a conventional three-electrode system, using a glassy carbon electrode (GCE, 3 mm) as the working electrode. Platinum wire was used as the counter electrode and Ag / AgCl (3M KCl) as the reference electrode. Silver wire was selected as the reference electrode for all organic phase detections.
[0028] Example 1: The preparation process of BDPPA small molecule is as follows:
[0029] (1) The specific synthesis steps of BDPPA small molecule are as follows Figure 1 As shown: Compound 1 (1.0mmol, 0.626g), diphenylamine (10.0mmol, 1.692g), Pd2(dba)3 (0.076mmol, 0.044g), Ruphos (0.30mmol, 0.140g), K3PO4 (10.0mmol, 2.122g) were dissolved in toluene (4mL). The mixture was then degassed and heated at 110°C under nitrogen for 24h. The reaction mixture was cooled to room temperature, and then water (30ml) and chloroform (50ml) were added. The organic layer was separated and washed with brine, dried over anhydrous MgSO4, and evaporated to dryness under reduced pressure. The crude product was purified by silica gel chromatography (light petroleum: CH2Cl2=1:1), and then recrystallized from CHCl3 / hexane to obtain BDPPA. Yield: 65%, the desired compound was obtained as a red solid. The BDPPA small molecule was characterized as follows Figure 2 As shown. Figure 2 (A) can be obtained, as the water content (f w ) increases from 0 to 70%, the fluorescence intensity gradually decreases, which may be attributed to the transition of the twisted intramolecular charge transfer (TICT) state in the donor-acceptor structure. With the continuous increase of H2O content, the fluorescence intensity of BDPPA is significantly enhanced, indicating the existence of obvious AIE phenomenon. Figure 2 In (B), it can be observed that the electrons in the highest occupied molecular orbital (HOMO) are mainly distributed on the central benzene ring and the diphenylamine group. In addition, the lowest unoccupied molecular orbital (LUMO) is mainly distributed on the CNC=C-C6H4-C=CCN framework. The above findings confirm the existence of stable electron transfer in BDPPA. Figure 2(C) The single crystal structure of BDPPA was obtained by X-ray analysis, revealing a distorted molecular structure. The dihedral angle between the central benzene ring plane and the phenyl group with substituents is 35.2°. Figure 2 In (D), the conformation of the BDPPA molecule shows a non-planar structure, no π-π stacking is observed between adjacent molecules, and the distance between the central benzene ring planes is This can avoid intermolecular π-π interactions and thus prevent fluorescence quenching in the solid or aggregated state.
[0030] (2) Preparation of BDPPANPs: Nanoparticles were prepared by nano-coprecipitation method. Briefly, stock solutions of BDPPA (1 mg / mL) and PSMA (1 mg / mL) were prepared in 1 mL of THF. After ultrasonication for 10 min, 320 μL of BDPPA solution was mixed with 80 μL of PSMA solution and diluted with 1.6 mL of THF to obtain a uniform mixture. Then, the homogenate was quickly injected into ultrapure water (10 mL) and ultrasonicated in an ice bath for another 4 min. Under nitrogen purge, the nanoparticle dispersion was concentrated by removing THF. BDPPANPs were then obtained by filtration with a filter membrane with a diameter of 0.22 μm. The characterization of BDPPANPs is as follows. Figure 3 shown. Figure 3 (A) Transmission electron microscopy (TEM) images show that BDPPANPs present a monodisperse spherical structure with a particle size of 34 nm. The dynamic light scattering (DLS) method measures that its hydrated particle size is approximately 40 nm. Figure 3 (B) shows the UV-visible absorption spectrum of BDPPA nanoparticles, whose characteristic absorption peak is consistent with that of BDPPA molecules. At the same time, the fluorescence emission spectrum (FL spectrum) of BDPPA nanoparticles in aqueous solution shows a red emission peak at 658nm. Furthermore, under 488nm laser excitation, the fluorescence brightness of a single particle was measured using a fluorescence microscope, and the fluorescence signal was filtered out by a 600nm long-pass filter. Figure 3 As can be seen in (C), a large number of bright fluorescent spots were observed on the glass substrate, which corresponded to individual nanoparticles. Figure 3 Middle (D) Figure 3 C 3D surface plot of the fluorescence image, indicating that the majority of single-particle brightness was counted as 43889 counts. The excellent optical properties suggest that the prepared NPs may be promising candidates for downstream ECL analysis.
[0031] Example 2: ECL mechanism of BDPPANPs and assembly of immunosensor
[0032] like Figure 4As shown in (A), the anodic ECL mechanism of the BDPPANPs / TPrA system can be described as follows:
[0033] Be - →B ·+ (1)
[0034] TPrA-e - →TPrAH ·+ (2)
[0035] TpA ·+ -H + →TPrA · (3)
[0036] B ·+ +TPrA · →B * +TPrA ox (4)
[0037] B * →B+hv (5)
[0038] First, BDPPANPs (abbreviated as B) and TPrA were oxidized to and (Formulas (1) and (2)). ·+ The deprotonated product was identified as a highly reducing free radical (Eq. (3)). This free radical can effectively reduce Generate excited state B* and produce ECL radiation (Equations (4) and (5)).
[0039] The cathode ECL reaction can be expressed as follows:
[0040]
[0041] B+e - →B ·- (7)
[0042]
[0043] B * →B+hv (9)
[0044] Compared with the cathode region, the anodic ECL of BDPPANPs / GCE exhibits relatively low excitation potential and higher emission efficiency. Therefore, this study focuses on exploring the anodic ECL of BDPPANPs to lay the foundation for subsequent biosensing applications. In addition, compared with [Ru(bpy)3] 2+Compared with the / TPrA standard system, the relative ECL efficiency obtained by the BDPPA NPs / TPrA system in PBS solution was 54% (designated as 100%), indicating that its ECL efficiency is higher than that of the traditional AIECL emission source.
[0045] like Figure 4 As shown in (B), first, the GCE was polished with 1.0, 0.3, and 0.05 μm alumina powders, respectively, and then cleaned alternately in ethanol and ultrapure water using ultrasonic waves. Then, 6 μL of the prepared BDPPA NPs (160 μg mL -1 ) was modified on the GCE surface and dried at 25°C to prepare BDPPANPs / GCE. Then, the GCE modified with the above NPs was immersed in a crosslinker (20mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)) and 10mM N-hydroxysuccinimide (NHS) and incubated at room temperature for 30min. Then, 4μLAb (10μg / mL) was incubated with the modified electrode at 4°C for 12h (Ab / BDPPA NPs / GCE), and then incubated with 4μL BSA (1%) (BSA / Ab1 / BDPPANPs / GCE) at 25°C for 30min to prevent nonspecific adsorption. Finally, 10μL of SARS-CoV-2N protein of different concentrations was incubated with the modified electrode BSA / Ab1 / BDPPANPs / GCE at 37°C for 60min to prepare a label-free immunosensor for antigen-antibody specific recognition. After each modification step, unbound components were removed using PBS (0.01 M, pH 7.4).
[0046] Example 3: Verification of the AIECL properties of BDPPANPs
[0047] To confirm whether BDPPA has AIECL properties, ECL-time curves were obtained in the organic phase (THF) and the aqueous phase (PBS) (0.1 M, pH 7.4). Figure 5 As shown in (A), in TBAPF6 / THF (0.1 M) solution containing 25 mM TPrA, the ECL intensity of BDPPA monomer is less than 400 a.u. The non-emissive behavior of BDPPA monomer can be attributed to the high-frequency rotation and vibration modes exhibited by the benzene ring in THF, leading to the non-radiative annihilation of the excited state. However, with the same co-reactants, the ECL emission of BDPPANPs / GCE is 400 times higher than that of BDPPA monomer. The significant difference in the ECL response between NPs and monomers can be attributed to the distorted molecular configuration, which restricts the intramolecular free movement of BDPPA and reduces the non-radiative transitions of the intense ECL emission. Under the optimal experimental conditions, the anodic CV and ECL behaviors of BDPPANPs / GCE were studied. As shown Figure 5As shown in (B), the BDPPANPs / GCE in PBS shows an obvious oxidation peak at 1.3 V (curve a), indicating that BDPPANPs is electrochemically oxidized to form cationic radicals through hole injection into HOMO, and the ECL signal is minimal ( Figure 5 (C) curve, curve a). At the same time, due to the oxidation of TPrA, TPrA has an irreversible anodic current peak at +0.95V, and the starting potential at GCE is +0.57V ( Figure 5 In curve b), a negligible ECL signal is observed ( Figure 5 (C), curve b). However, due to the poor conductivity of BDPPA, the oxidation current decreased slightly when it was modified onto GCE ( Figure 5 (B), curve c). Interestingly, in the presence of TPrA, a strong ECL emission was observed on the BDPPA nanoparticles / GCE ( Figure 5 In (C), curve c), the starting potential is +0.80V. The strong ECL emission originates from the efficient reaction between the intermediates electrochemically generated by TPrA and the BDPPA nanoparticles. This low trigger potential can be attributed to the strong ICT transition of the electron donor-acceptor structure with a narrow band gap in the BDPPA molecular structure. In addition, the PL and ECL spectra of the BDPPA nanoparticle / TPrA system were also studied. The ECL spectrum of the indium tin oxide (ITO) electrode modified with BDPPA nanoparticles was recorded under a constant potential scan of +1.60V. Interestingly, the maximum emission peak of the ECL spectrum is located at 660nm, which matches the fluorescence emission peak (658nm), indicating that the ECL mode is bandgap ECL emission. The ECL and fluorescence of BDPPA nanoparticles undergo the same process, including the transition from excited state to ground state and then to subsequent luminescence. The ECL image of BDPPA nanoparticles taken by iPhone 12 appears bright red, corresponding to the ECL spectrum peak (660nm) ( Figure 5 In addition, the CIE chromaticity diagram also confirms the uniformity of ECL and PL emissions ( Figure 5 (E)).
[0048] Example 4: Performance study of ECL immunosensor in SARS-CoV-2N protein detection:
[0049] like Figure 6 As shown in (A), as the concentration of N protein increases, the ECL intensity gradually decreases. Figure 6 In (B), the ECL intensity is related to the N protein concentration (ranging from 0.001 ng mL -1 to 500ng mL -1), the linear fitting equation is I = 64626.2-19143.2×logC(R 2 =0.998). The limit of detection (LOD) was determined to be 0.28 pg mL -1 (Signal-to-noise ratio = 3), exceeding the reported SARS-CoV-2 protein detection strategy, thus showing an exceptional sensitivity for N protein detection. Figure 6 As can be seen in (C), under the interference of interleukin-6 (IL-6), carcinoembryonic antigen (CEA), C-reactive protein (CRP) and interleukin-8 (IL-8), the decrease in ECL response can be ignored and is close to that of the blank solution, while only the SARS-CoV-2N protein solution (1 ng mL -1 ) or mixed solutions will lead to a significant decrease in ECL intensity, and there is no obvious difference, indicating that the specificity is excellent. Figure 6 As shown in (D), the immunosensor was stored at 4°C for 10 days, and the concentration of N protein was regularly checked and tested every 2 days to evaluate its stability. The results show that the immunosensor has good storage stability. Figure 6 As shown in (E), five different immunosensors were combined with N protein (1 ng mL -1 ) and detected in the same array. -1 ) A similar immunosensor was incubated in five different arrays. The inter- and intra-assay RSD values were 3.2% and 2.5%, respectively, indicating that the proposed immunosensor has satisfactory reproducibility and excellent precision.
[0050] In addition, to evaluate the practicality of the immunosensor, standard addition was used to detect SARS-CoV-2 N protein in human serum. The N protein solution was added to human serum diluted 20 times with PBS of different standard concentrations, and the immunosensor developed in this study had a high recovery rate (98.0% to 108.2%) and a low RSD (1.5% to 3.4%), showing its potential for detecting SARS-CoV-2 N protein in real clinical samples.
[0051] The preferred embodiments of the present invention have been specifically described above, but the present invention is not limited to the embodiments. Those skilled in the art may make various equivalent modifications or substitutions without violating the spirit of the present invention. These equivalent modifications or substitutions are all included in the scope defined by the claims of this application.
Claims
1. A method for preparing an electrochemiluminescent immunosensor based on AIECL, characterized in that: The following steps are included: Step 1, preparing BDPPA small molecule; Step 2: synthesizing BDPPANPs by nanoprecipitation method; the BDPPANPs is spherical, and its structure is acceptor-conjugated bridge-donor-conjugated bridge-acceptor; Step 3: Construction of electrochemiluminescent immunosensor based on BDPPANPs.
2. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 1, characterized in that: Step 1 specifically includes: Compound 1, diphenylamine, Pd2(dba)3, Ruphos, and K3PO4 were dissolved in toluene to obtain a mixture 1; The mixture 1 is degassed and heated to obtain a mixture 2; the structure of compound 1 is: The mixture 2 was cooled to room temperature, and then water and chloroform were added; the organic layer was separated and washed with brine, dried over anhydrous MgSO4, and evaporated to dryness under reduced pressure to give a crude product; The crude product was purified by silica gel chromatography and recrystallized from CHCl3 / hexane to give BDPPA.
3. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 1, characterized in that: Step 2 specifically includes: Mix the BDPPA solution with the PSMA solution, and then dilute with THF to obtain a uniform mixture; The homogenized mixture was poured into ultrapure water and sonicated again in an ice bath; the nanoparticle dispersion was concentrated by removing THF under nitrogen purge; The nanoparticle dispersion was filtered through a membrane filter to obtain BDPPANPs.
4. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 1, characterized in that: Step 3 specifically includes: (1) The GCE was polished and then cleaned alternately in ethanol and ultrapure water using ultrasonic waves; (2) BDPPANPs were modified on the surface of GCE and dried to obtain BDPPANPs / GCE; (3) Incubate BDPPANPs / GCE in cross-linking agent and NHS; (4) incubating Ab with the BDPPANPs / GCE obtained after treatment in step (3), and then incubating with BSA to obtain BSA / Ab / BDPPANPs / GCE; (5) Different concentrations of SARS-CoV-2N protein were incubated with BSA / Ab / BDPPANPs / GCE at 37°C to prepare a label-free immunosensor with antigen-antibody specific recognition.
5. The method for preparing an electrochemiluminescence immunosensor based on AIECL according to claim 4, characterized in that: The cross-linking agent is 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
6. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 4, characterized in that: In step (1), the GCE was polished with 1.0, 0.3 and 0.05 μm alumina powders respectively.
7. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 4, characterized in that: The concentration of BDPPANPs in step (2) was 160 μg mL -1 .
8. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 4, characterized in that: In step (3), the concentration of the cross-linking agent is 20 mM, and the concentration of NHS is 10 mM.
9. The method for preparing an electrochemiluminescent immunosensor based on AIECL according to claim 4, characterized in that: In step (4), Ab was incubated with BDPPANPs / GCE at 4°C for 12 h, and then incubated with BSA at 25°C for 30 min.
10. Application of the electrochemiluminescent immunosensor prepared by the preparation method according to any one of claims 1 to 9 in quantitative analysis of SARS-CoV-2N protein.
